β¨ Foreign Affairs and Health Notices
2474
NEW ZEALAND GAZETTE
No. 94
Foreign Affairs and Trade
Diplomatic Privileges and Immunities Act 1968
Privileges and Immunities of Representatives of Pacific Islands Forum Countries and Their Official Staff Attending the Pacific Islands Forum Meetings
Pursuant to section 11 of the Diplomatic Privileges and Immunities Act 1968 ("the Act"), the Minister of Foreign Affairs and Trade declares that:
-
Representatives of the Pacific Islands Forum member and observer countries, including New Zealand, will be attending the Pacific Islands Forum to be held in Auckland from 12 August 2003 to 19 August 2003; and
-
In order to clarify the privileges and immunities which may be enjoyed by those representatives and their official administrative and support staff attending the said meeting;
directs that:
(a) every representative (including official delegates) of the Pacific Islands Forum member and observer countries (other than of New Zealand) shall be accorded the privileges and immunities conferred by or by virtue of Part I of the Act on a diplomatic agent as specified in Articles 29 to 37 (1) inclusive of the Vienna Convention on Diplomatic Relations, set out in the First Schedule to the Act; and
(b) the members of the official administrative and support staff of any such representative shall be accorded the following privileges and immunities:
(i) Immunity from suit and legal process in respect of things done or omitted to be done by them in the course of the performance of their official duties;
(ii) exemption from income tax in respect of emoluments received for services in respect of their official duties; and
(iii) exemption from duties and taxes on the importation of goods for official use in New Zealand, that exemption to be subject to compliance with such conditions as the Minister of Customs may determine for the protection of the revenue.
Dated at Wellington this 4th day of August 2003.
PHIL GOFF, Minister of Foreign Affairs and Trade.
go5132
Health
Medicines Act 1981
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Amyl Nitrite Inhalant
Active Ingredient: Amyl nitrite 98%w/v
Dosage Form: Volatile liquid for inhalation
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: James Alexander Corporation, Blairstown, New Jersey, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 1st day of August 2003.
G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).
go5095
Provisional Consent to the Distribution of a New Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Diabex
Active Ingredient: Metformin hydrochloride 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Lipha SA, Le Pressoir Vert, Semoy, France
Note: This consent is valid for six months from the date of publication of this notice.
Product: Diabex
Active Ingredient: Metformin hydrochloride 850mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Lipha SA, Le Pressoir Vert, Semoy, France
Next Page →
Online Sources for this page:
VUW Te Waharoa —
NZ Gazette 2003, No 94
Gazette.govt.nz —
NZ Gazette 2003, No 94
β¨ LLM interpretation of page content
π Privileges and Immunities for Pacific Islands Forum Representatives
π External Affairs & Territories4 August 2003
Diplomatic Privileges, Pacific Islands Forum, Immunities, Auckland, Representatives, Official Staff
- PHIL GOFF, Minister of Foreign Affairs and Trade
π₯ Provisional Consent for Amyl Nitrite Inhalant
π₯ Health & Social Welfare1 August 2003
Medicines Act, Provisional Consent, Amyl Nitrite Inhalant, Baxter Healthcare, James Alexander Corporation
- G. R. BOYD, Chief Advisor, Safety and Regulation
π₯ Provisional Consent for Diabex
π₯ Health & Social Welfare1 August 2003
Medicines Act, Provisional Consent, Diabex, Metformin hydrochloride, Pacific Pharmaceuticals, Lipha SA
- G. R. BOYD, Chief Advisor, Safety and Regulation